I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glomerular endothelial cell | 4 studies | 31% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glomerular endothelial cell | 4 studies | 31% ± 8% |
Insufficient scRNA-seq data for expression of IL13RA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 82% | 165.32 | 201 / 245 | 62% | 4.41 | 311 / 502 |
| adrenal gland | 33% | 100.89 | 85 / 258 | 83% | 101.97 | 191 / 230 |
| brain | 50% | 148.57 | 1320 / 2642 | 53% | 23.24 | 373 / 705 |
| kidney | 71% | 141.51 | 63 / 89 | 30% | 2.52 | 271 / 901 |
| skin | 30% | 437.06 | 543 / 1809 | 50% | 82.69 | 235 / 472 |
| lung | 43% | 93.34 | 250 / 578 | 34% | 4.91 | 387 / 1155 |
| thymus | 42% | 50.77 | 277 / 653 | 26% | 3.12 | 157 / 605 |
| bladder | 19% | 125.33 | 4 / 21 | 34% | 6.93 | 171 / 504 |
| liver | 42% | 65.58 | 94 / 226 | 11% | 3.67 | 45 / 406 |
| esophagus | 9% | 13.91 | 135 / 1445 | 42% | 3.76 | 76 / 183 |
| blood vessel | 51% | 560.32 | 678 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 6% | 5.92 | 55 / 966 | 33% | 2.38 | 172 / 527 |
| stomach | 4% | 4.58 | 13 / 359 | 32% | 2.10 | 92 / 286 |
| uterus | 6% | 5.56 | 10 / 170 | 25% | 9.22 | 115 / 459 |
| pancreas | 0% | 0.17 | 1 / 328 | 29% | 6.19 | 51 / 178 |
| breast | 12% | 13.62 | 55 / 459 | 9% | 1.03 | 100 / 1118 |
| adipose | 20% | 25.50 | 237 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 1% | 0.56 | 2 / 180 | 17% | 2.74 | 72 / 430 |
| heart | 11% | 10.14 | 91 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 1.56 | 3 / 29 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.65 | 7 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.96 | 3 / 45 |
| spleen | 2% | 2.12 | 6 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 0.95 | 7 / 929 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.36 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0043305 | Biological process | negative regulation of mast cell degranulation |
| GO_0002638 | Biological process | negative regulation of immunoglobulin production |
| GO_0016064 | Biological process | immunoglobulin mediated immune response |
| GO_0005615 | Cellular component | extracellular space |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0043235 | Cellular component | receptor complex |
| GO_0005576 | Cellular component | extracellular region |
| GO_0019955 | Molecular function | cytokine binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0004896 | Molecular function | cytokine receptor activity |
| Gene name | IL13RA2 |
| Protein name | Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2) Interleukin-13 receptor alpha 2 variant |
| Synonyms | IL13R |
| Description | FUNCTION: Binds as a monomer with high affinity to interleukin-13 (IL13), but not to interleukin-4 (IL4). . |
| Accessions | Q14627 ENST00000371936.5 ENST00000243213.2 D0EFR8 |
